LINDE PLC (LIN) Most Active Options

The 25 most actively traded LINDE PLC (LIN) option contracts at the latest daily snapshot, ranked by volume. Each row shows the contract's price, implied volatility, delta, open interest, and how today's volume compares with its own 30-day average — click a contract to analyze it in the OptiView platform.

Data as of Jul 10, 2026, 8:00 PM ET · OPRA data 15 minutes delayed · For information only — not investment advice.

Last close
$537.69
52-week range
$389.14 – $546.79
ATM IV (30d)
19.8%
IV rank
39 / 100
Low
Expected move
±$14.72 (±2.7%)
Put/call OI
1.32
Put-heavy
Max pain
$510
↓ 5.1% below close
Next earnings
Jul 30, 2026

Most Active LIN Contracts

ContractExpirationDTELastIV IV rank (30d)DeltaOpen interestVolumevs 30d avg
LIN $530 call Jul 17, 2026 7d $7.62 18.3% 59 0.60 608 92 3.3× avg
LIN $510 put Jul 17, 2026 7d $1.15 34.5% 8 -0.17 1,135 89 8.9× avg
LIN $560 call Jul 17, 2026 7d $0.75 25.7% 38 0.09 618 69 2.1× avg
LIN $515 put Jul 17, 2026 7d $1.75 29.9% 68 -0.19 226 57 5.5× avg
LIN $505 put Jul 17, 2026 7d $0.90 32.8% 5 -0.11 498 57 5.7× avg
LIN $555 call Jul 17, 2026 7d $1.00 33.1% 76 0.20 154 55 1.7× avg
LIN $550 call Jul 17, 2026 7d $1.39 19.9% 8 0.13 401 44 1.4× avg
LIN $495 put Oct 16, 2026 98d $11.80 26.6% 63 -0.26 28 42 12.0× avg
LIN $595 call Jan 15, 2027 189d $16.90 24.2% 40 0.32 24 41 11.7× avg
LIN $480 call Mar 19, 2027 252d $81.10 25.9% 20 0.75 8 39 45.4× avg
LIN $535 call Jul 17, 2026 7d $5.30 19.8% 64 0.46 483 22 0.8× avg
LIN $500 put Jan 15, 2027 189d $21.70 26.4% 59 -0.31 252 19 5.4× avg
LIN $500 call Mar 19, 2027 252d $67.60 25.4% 15 0.69 30 18 20.9× avg
LIN $540 call Oct 16, 2026 98d $25.31 23.6% 18 0.50 31 16 5.0× avg
LIN $540 call Jul 17, 2026 7d $3.50 18.4% 0 0.32 332 14 0.4× avg
LIN $600 call Jan 15, 2027 189d $15.90 24.3% 44 0.30 143 14 4.0× avg
LIN $540 put Jul 17, 2026 7d $11.80 29.4% 28 -0.61 772 14 2.1× avg
LIN $560 call Aug 21, 2026 42d $7.77 23.7% 29 0.30 38 13 1.2× avg
LIN $640 call Jan 15, 2027 189d $8.60 23.6% 8 0.18 128 13 13.4× avg
LIN $490 call Mar 19, 2027 252d $74.20 25.6% 18 0.72 12 10 11.6× avg
LIN $605 call Jan 15, 2027 189d $14.70 24.3% 42 0.29 79 9 2.6× avg
LIN $515 put Jan 15, 2027 189d $26.40 26.1% 98 -0.36 41 9 2.3× avg
LIN $415 put Jan 15, 2027 189d $4.92 27.8% 17 -0.08 8 8 9.4× avg
LIN $450 call Mar 19, 2027 252d $103.00 26.7% 16 0.83 7 8 12.6× avg
LIN $475 put Jan 15, 2027 189d $13.80 27.2% 71 -0.23 41 8 2.3× avg

Ranked by volume at the latest daily snapshot. "vs 30d avg" compares today's volume with the contract's own 30-day average.

The most active LIN contract today is the $530 call expiring in 7 days, with 92 contracts traded. Calls dominate the most-active list (16 of the top 25), showing where trading interest concentrates.

Explore the payoff profile of option on LIN for free

Build multi-leg LIN strategies, visualize payoffs, and scan the full US options universe with OptiView.

LIN Options FAQ

Which LIN option contract is most active today?

The most traded LIN contract is the $530 call expiring Jul 17, 2026, with 92 contracts traded as of Jul 10, 2026.

How does OptiView rank the most active LIN options?

The table lists the 25 LIN contracts with the highest volume at the latest daily snapshot, alongside price, implied volatility, delta, open interest, and each contract's volume versus its own 30-day average.

Methodology. IV rank compares the current 30-day at-the-money implied volatility with its highest and lowest values over the past 52 weeks. Max pain is the strike that minimizes the total payout to option holders at expiration. The call and put walls are the strikes carrying the largest call and put open interest across all expirations. Net gamma exposure (GEX) is measured from the dealer perspective. All statistics are derived from delayed OPRA options data.

Options trading involves significant risk, and losses can exceed your initial investment. Always consult a licensed financial professional before making investment decisions. OptiView does not provide financial advice; all figures on this page are descriptive statistics, not recommendations.